JLE

European Journal of Dermatology

MENU

Anti-MDA5 antibody-positive dermatomyositis with lethal progressive interstitial lung disease and advanced gastric cancer Volume 24, numéro 4, Juillet-Août

Illustrations


  • Figure 1
Auteurs
1 Department of Dermatology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan
2 Department of Dermatology, Higashiosaka City General Hospital, Osaka, Japan
3 Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan

Dermatomyositis (DM) is an autoimmune inflammatory disease often associated with internal malignancy and interstitial lung disease. The latter is found in about 50% of patients with DM and is a life-threatening complication of the disease [1]. Rapidly progressive interstitial lung disease (RP-ILD) associated with clinically amyopathic dermatomyositis (CADM) is often lethal, despite treatment by corticosteroid therapy combined with immunosuppressive drugs [2].A number of autoantibodies can be detected [...]